ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	4/11	120/7206	2.20556234989e-05
ko01521	EGFR tyrosine kinase inhibitor resistance	3/11	106/7206	0.000468521015103
ko04012	ErbB signaling pathway	3/11	109/7206	0.000508560580687
ko05205	Proteoglycans in cancer	4/11	271/7206	0.00052374312698
ko05215	Prostate cancer	3/11	111/7206	0.000536442019282
ko04915	Estrogen signaling pathway	3/11	131/7206	0.000870763769242
ko04931	Insulin resistance	3/11	137/7206	0.00099197867694
ko04010	MAPK signaling pathway	4/11	321/7206	0.000994187426841
ko05160	Hepatitis C	3/11	153/7206	0.00136642543545
ko05161	Hepatitis B	3/11	173/7206	0.00194690083268
ko05206	MicroRNAs in cancer	3/11	177/7206	0.00207891186263
ko04210	Apoptosis	3/11	180/7206	0.00218153219336
ko04215	Apoptosis - multiple species	2/11	47/7206	0.00220600572258
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/11	182/7206	0.00225168580458
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/11	191/7206	0.00258490572535
ko04060	Cytokine-cytokine receptor interaction	3/11	191/7206	0.00258490572535
ko05213	Endometrial cancer	2/11	62/7206	0.00381105234612
ko05223	Non-small cell lung cancer	2/11	66/7206	0.00430857215997
ko05014	Amyotrophic lateral sclerosis (ALS)	2/11	74/7206	0.00538934631348
ko01524	Platinum drug resistance	2/11	76/7206	0.00567718096712
ko05214	Glioma	2/11	79/7206	0.00612201151205
ko05230	Central carbon metabolism in cancer	2/11	81/7206	0.00642722994048
ko05212	Pancreatic cancer	2/11	83/7206	0.006739336873
ko05218	Melanoma	2/11	85/7206	0.0070582953544
ko05210	Colorectal cancer	2/11	86/7206	0.00722033241208
ko05203	Viral carcinogenesis	3/11	277/7206	0.00736900810099
ko04657	IL-17 signaling pathway	2/11	87/7206	0.00738406855637
ko04662	B cell receptor signaling pathway	2/11	88/7206	0.00754949920344
ko05120	Epithelial cell signaling in Helicobacter pylori infection	2/11	92/7206	0.00822807542033
ko04650	Natural killer cell mediated cytotoxicity	2/11	97/7206	0.00911387522882
ko05146	Amoebiasis	2/11	99/7206	0.00947977042577
ko04066	HIF-1 signaling pathway	2/11	123/7206	0.0143720699243
ko04211	Longevity regulating pathway	2/11	123/7206	0.0143720699243
ko01522	Endocrine resistance	2/11	124/7206	0.0145955156759
ko05145	Toxoplasmosis	2/11	126/7206	0.0150469939754
ko05142	Chagas disease (American trypanosomiasis)	2/11	130/7206	0.0159681778674
ko05231	Choline metabolism in cancer	2/11	134/7206	0.0169134375484
ko04380	Osteoclast differentiation	2/11	134/7206	0.0169134375484
ko04933	AGE-RAGE signaling pathway in diabetic complications	2/11	135/7206	0.0171534825044
ko04151	PI3K-Akt signaling pathway	3/11	390/7206	0.0187468328814
ko04725	Cholinergic synapse	2/11	160/7206	0.0236259323509
ko04152	AMPK signaling pathway	2/11	161/7206	0.0239032011772
ko04071	Sphingolipid signaling pathway	2/11	162/7206	0.0241818465086
ko05164	Influenza A	2/11	167/7206	0.0255955802779
ko04068	FoxO signaling pathway	2/11	167/7206	0.0255955802779
ko05418	Fluid shear stress and atherosclerosis	2/11	173/7206	0.027336649755
ko05224	Breast cancer	2/11	174/7206	0.0276315015939
ko05168	Herpes simplex infection	2/11	182/7206	0.0300376798073
ko04150	mTOR signaling pathway	2/11	184/7206	0.030652237813
ko05152	Tuberculosis	2/11	187/7206	0.0315837088845
ko05200	Pathways in cancer	3/11	492/7206	0.0345603593115
ko04072	Phospholipase D signaling pathway	2/11	197/7206	0.0347708603348
ko05010	Alzheimer's disease	2/11	202/7206	0.0364110309467
ko05016	Huntington's disease	2/11	215/7206	0.0408167546166
ko04320	Dorso-ventral axis formation	1/11	31/7206	0.0463482979607
ko04510	Focal adhesion	2/11	240/7206	0.0498379403167